Matrix Capital Management Company, LP's Form 4 filing
Aura Biosciences, Inc.AURA · filed May 11, 2026
- Accession no.
- 0000950142-26-001346
- Filed
- May 11, 2026, 4:16 PM ET
- Trade date
- May 7, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $39.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Matrix Capital Management Company, LPCIK 0001410830 | 10% Owner |
| Goel David E.CIK 0001548144 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | Common Stock, par value $0.00001 per share (Common Stock) | SSaleDisposed | −6,922,870 | $5.64 | −$39,044,986.8 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.